Yearly Archives: 2025

/2025

Flu and COVID-19: NBS opens to post appointments

Pharmacy owners using the National Booking Service (NBS) to offer appointments for adult flu and COVID-19 vaccinations can now post appointments within the system, ahead of patients being able to use NBS to book appointments from 1st September 2025, for vaccination from 1st October 2025. The use of NBS for flu vaccinations is a voluntary [...]

The post Flu and COVID-19: NBS opens to post appointments appeared first on Community Pharmacy England.

By |August 19th, 2025|Lexpos News|Comments Off on Flu and COVID-19: NBS opens to post appointments

Obesity pathway innovation programme announced

On 12th August 2025 the Government and Lilly announced a health innovation programme of up to £85m, to be delivered by Innovate UK, to demonstrate new weight management pathways in the community. Through the programme, it is hoped that people living with obesity will be offered new types of holistic support to improve their health [...]

The post Obesity pathway innovation programme announced appeared first on Community Pharmacy England.

By |August 18th, 2025|Lexpos News|Comments Off on Obesity pathway innovation programme announced

MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited)

MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) Date issued: 14 August 2025 Drug Alert Number: EL(25)A/40 Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information. DMRC reference number: DMRC-35838218 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) appeared first on Community Pharmacy England.

By |August 14th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited)

Dapagliflozin tablets – changes to reimbursement from September 2025

Dapagliflozin 5mg and 10mg tablets will be moving from Category C to Category M in the September 2025 Drug Tariff. This comes after several manufacturers launched generic versions of Dapagliflozin tablets following the recent ruling by the UK Court of Appeal to invalidate AstraZeneca’s patent for the brand Forxiga®. Currently, all branded and generically written prescriptions [...]

The post Dapagliflozin tablets – changes to reimbursement from September 2025 appeared first on Community Pharmacy England.

By |August 14th, 2025|Lexpos News|Comments Off on Dapagliflozin tablets – changes to reimbursement from September 2025

Volunteer: Join the updated EPS status tracking NHS App pilot

Community pharmacy teams are invited to take part in a new NHS England pilot aimed at improving the prescription tracking experience for patients using the NHS App. NHS England is launching a pilot to enhance the experience of patients who use the NHS App to manage their prescriptions. NHS England is developing in-app notifications about [...]

The post Volunteer: Join the updated EPS status tracking NHS App pilot appeared first on Community Pharmacy England.

By |August 13th, 2025|Lexpos News|Comments Off on Volunteer: Join the updated EPS status tracking NHS App pilot